“Trapezia has been a fantastic investor for us – very supportive with our products and our management team.”

Allison Kibble, Managing Director

Femeda is a UK-based company which develops and commercialises products to treat female incontinence. The treatment and management of incontinence is a huge worldwide market, with an estimated annual spend of some US $12bn. Many women suffer in silence, believing their incontinence is an inevitable consequence of ageing and childbirth. Femeda offers treatments without visiting a healthcare professional.

www.femeda.com